Showing results (1-10 of 278) with videos related to
Sort By:
Pageof 28
The Journal of Clinical Investigation|April 24, 2018
Tandem bispecific broadly neutralizing antibody - a novel approach to HIV-1 treatmentGuido FerrariCurrent Opinion in HIV and AIDS|August 1, 2020
Engineering antibody-based molecules for HIV treatment and cureMarina Tuyishime, Guido FerrariMethods (San Diego, Calif.)|February 14, 2006
Measurement of cytokine release at the single cell level using the ELISPOT assayJosephine H Cox, Guido Ferrari, Sylvia JanetzkiJournal of Virus Eradication|September 16, 2022
Bispecific antibody-derived molecules to target persistent HIV infectionJeffrey L Nordstrom, Guido Ferrari, David M MargolisImmunological Reviews|January 31, 2017
HIV antibodies for treatment of HIV infectionDavid M Margolis, Richard A Koup, Guido FerrariMethods in Molecular Biology (Clifton, N.J.)|June 7, 2005
Standardization and validation issues of the ELISPOT assaySylvia Janetzki, Josephine H Cox, Neal Oden, et al.Current Opinion in HIV and AIDS|April 18, 2009
Neutralizing and other antiviral antibodies in HIV-1 infection and vaccinationDavid C Montefiori, Lynn Morris, Guido Ferrari, et al.The Journal of Infectious Diseases|May 19, 2017
Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV InfectionGuido Ferrari, Justin Pollara, Georgia D Tomaras, et al.Expert Review of Vaccines|September 23, 2006
Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV developmentMichael R Betts, Clive M Gray, Josephine H Cox, et al.Journal of Immunological Methods|March 30, 2016
Variability of the IFN-γ ELISpot assay in the context of proficiency testing and bridging studiesWes Rountree, Mark Berrong, Ana M Sanchez, et al.Pageof 28